FDA User Fees 2012: Hearing on Issues Related to Accelerated Approval, Medical Gas, Antibiotic Development and Downstream Pharmaceutical Supply Chain

Thursday, March 8, 2012 - 10:15am
2322 Rayburn
Background Documents and Information: 
Witnesses: 

Panel I

 

Janet Woodcock, MD

  • Director
  • Center for Drug Evaluation and Research
  • U.S. Food and Drug Administration
  • Witness Testimony

Panel II

 

John Maraganore, PhD.

Jeff Allen, PhD.

Barry Eisenstein, M.D., FACP, FIDSA, FAAM

John H. Powers, MD, FACP, FIDSA

  • Assistant Clinical Professor of Medicine
  • George Washington University School of Medicine
  • Witness Testimony

Michael D. Walsh

Panel III

 

Shawn Brown

Elizabeth A. Gallenagh, JD

Tim Davis, Pharm.D.

Allan Coukell

Congress: